Deep Track Capital, LP Hille Vax, Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 2,572,460 shares of HLVX stock, worth $31.2 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
2,572,460
Previous 2,900,000
11.29%
Holding current value
$31.2 Million
Previous $46.5 Million
8.09%
% of portfolio
1.41%
Previous 1.77%
Shares
2 transactions
Others Institutions Holding HLVX
# of Institutions
82Shares Held
39MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.78MShares$119 Million8.54% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4MShares$48.6 Million1.38% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.06MShares$37.2 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY2.08MShares$25.2 Million2.96% of portfolio
-
Franklin Resources Inc San Mateo, CA1.85MShares$22.5 Million0.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $406M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.